Genmab A (GMAB) Inventory Average (2025 - 2026)
Genmab A's (GMAB) quarterly Inventory Average came in at $19.5 million in Q1 2026, up 85.71% YoY from $10.5 million in Q1 2025, and up 21.88% on a QoQ basis from $16.0 million in Q4 2025.
Genmab A (GMAB) Inventory Average (2025 - 2026) Analysis & Trends
Genmab A (GMAB) has 2 years of Inventory Average data on file, last reported at $19.5 million in Q1 2026.
- Quarterly Inventory Average rose 85.71% year-over-year to $19.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.5 million (up 85.71% YoY) and the FY2025 annual result came in at $15.0 million, changed N/A from the prior year.
- Inventory Average grew to $19.5 million in Q1 2026, from $16.0 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $19.5 million in Q1 2026 to a low of $10.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Genmab A | 2.05 Bn | 548.77 Mn | 1.07 Bn | 19.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.50 Mn |
| Mar 31, 2026 | 19.50 Mn |
| Dec 31, 2025 | 16.00 Mn |
| Sep 30, 2025 | 13.50 Mn |
| Jun 30, 2025 | 12.50 Mn |
| Mar 31, 2025 | 10.50 Mn |